Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
peripheral artery disease
MedTech
Abbott absorbable stent for peripheral arteries heads to Europe
Abbott said the CE mark opens up the Esprit BTK scaffold to more than 50 million people on the continent—about twice the population in the U.S.
Conor Hale
Aug 26, 2025 12:35pm
FDA clears Reflow Medical’s retrievable below-the-knee stent
Jun 9, 2025 11:00am
J&J's Shockwave launches path-clearing Javelin catheter in PAD
Mar 5, 2025 10:47am
FDA elevates recall as Philips pulls implant from the market
Mar 4, 2025 2:35pm
Boston Scientific zaps Bolt in intravascular lithotripsy buy
Jan 8, 2025 11:00am
Abbott posts positive, longer-term data for its Esprit BTK stent
Nov 5, 2024 11:00am
